| |
Latest 10 SEC filings (by transaction date) for PHAT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 10/24 | Apr 8/24 | Henderson Molly | Direct Ownership | Common Stoock | S - Open market or private sale | -3,435 | $11.10 |
Mar 26/24 | Mar 22/24 | Curran Terrie | Direct Ownership | Common Stock | S - Open market or private sale | -16,851 | $9.11 |
Jan 26/24 | Jan 26/24 | Medicxi Ventures Management (Jersey) Ltd | Indirect Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jan 26/24 | Jan 26/24 | Medicxi Ventures Management (Jersey) Ltd | Indirect Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jan 26/24 | Jan 26/24 | Medicxi Ventures Management (Jersey) Ltd | Indirect Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jan 26/24 | Jan 26/24 | Medicxi Ventures Management (Jersey) Ltd | Indirect Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jan 25/24 | Jan 24/24 | Takeda Pharmaceutical Co Ltd | Direct Ownership | Common Stock | S - Open market or private sale | -3,703,703 | $8.10 |
Jan 22/24 | Jan 19/24 | Henderson Molly | Direct Ownership | Common Stock | S - Open market or private sale | -6,307 | $7.75 |
Jan 22/24 | Jan 18/24 | Henderson Molly | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 120,000 | |
Jan 22/24 | Jan 18/24 | Nabulsi Azmi | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 130,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for PHAT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 10/24 | Apr 8/24 | Henderson Molly | Direct Ownership | Common Stoock | S - Open market or private sale | -3,435 | $11.10 |
Mar 26/24 | Mar 22/24 | Curran Terrie | Direct Ownership | Common Stock | S - Open market or private sale | -16,851 | $9.11 |
Jan 26/24 | Jan 26/24 | Medicxi Ventures Management (Jersey) Ltd | Indirect Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jan 26/24 | Jan 26/24 | Medicxi Ventures Management (Jersey) Ltd | Indirect Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jan 26/24 | Jan 26/24 | Medicxi Ventures Management (Jersey) Ltd | Indirect Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jan 26/24 | Jan 26/24 | Medicxi Ventures Management (Jersey) Ltd | Indirect Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jan 25/24 | Jan 24/24 | Takeda Pharmaceutical Co Ltd | Direct Ownership | Common Stock | S - Open market or private sale | -3,703,703 | $8.10 |
Jan 22/24 | Jan 18/24 | Henderson Molly | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 120,000 | |
Jan 22/24 | Jan 19/24 | Henderson Molly | Direct Ownership | Common Stock | S - Open market or private sale | -6,307 | $7.75 |
Jan 22/24 | Jan 18/24 | Nabulsi Azmi | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 130,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Medpace Holdings (OQ:MEDP) |
United Therapeutics (OQ:UTHR) |
Disc Medicine (OQ:IRON) |